The purpose of this Funding Opportunity Announcement (FOA) is to increase our understanding of persistent HIV-1 infection in patients under highly active anti-retroviral therapy (HAART). Support would be through soliciting applications for hypothesis-driven basic research in HIV/AIDS that is focused on directly achieving this aim. The emphasis of this initiative is on the development of new ideas and approaches in HIV-1 persistence including model and assay development that may directly inform future studies on the design of therapeutic strategies to achieve long term remission without treatment or a complete eradication of residual virus and complete cure for HIV infection and AIDS.
There are two mechanisms to available to apply for this grant:
This opportunity will have regular deadlines until January 2015. The next deadline is 7 September 2012.
